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Abstract Oxidation of low density lipoprotein (LDL) induced
by hypochlorous acid (HOCl) leading to LDL3, a minimally
oxidized subspecies of LDL, was investigated. LDL3 is
characterized by its greater electronegativity and oxidative
status, and is found in plasma in vivo. Its concentration was
found to be elevated under conditions that predispose humans to
atherosclerosis. We found that HOCl also converts LDL rapidly
to an even more oxidized state, identified as LDL23, which is
more electronegative than LDL3. After milder oxidation for
short durations, formation of LDL3 takes place while less
LDL23 is formed. Under these conditions, addition of methionine
not only suppressed further oxidation of LDL but also favored
the formation of LDL3 over LDL23, possibly by removing
chloramines at lysyl residues of LDL. The presence of
lipoprotein-deficient plasma did not prevent HOCl-mediated
conversion of LDL to more electronegative species. It is
concluded that the HOCl-mediated conversion of LDL into
more electronegative species might be physiologically
relevant. ß 2001 Published by Elsevier Science B.V. on behalf
of the Federation of European Biochemical Societies.
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1. Introduction
Low density lipoprotein (LDL) is a heterogeneous collec-
tion of particles which vary in size [1], density [2], composition
[3], and charge [4]. Based on di¡erences in charge, plasma
LDL is readily separated by anion exchange chromatography
into three fractions. The major fraction, native LDL (nLDL),
represents V90^99% of total LDL. The other two fractions
have been operatively termed LDL3 and LDL23, the termi-
nology used refers to the increase in oxidized status and elec-
tronegativity [5]. LDL23 constitutes 0.1^1% of total LDL and
appears to be a highly oxidized subfraction of LDL. LDL3
represents 0.2^8% of LDL, and is predominantly found in the
small, dense LDL fraction [6] which is strongly associated
with an increased risk of atherosclerosis [7].
LDL3 is found in vivo in the circulation and displays subtle
changes in protein composition. Agarose gel electrophoresis
shows increased negative charge density compared to nLDL.
LDL3 is enriched in oxidized lipids, e.g. lipid hydroperoxides
and oxysterols [8]. It binds with diminished a⁄nity to LDL
receptors of human skin ¢broblasts and endothelial cells [9]
but is a poor ligand for macrophage scavenger receptor [10].
In contrast to nLDL, LDL3 is cytotoxic to cultured endothe-
lial cells [11].
In£ammation is strongly associated with an increased risk
of atherosclerosis [12]. Phagocytic white blood cells (mono-
cytes, macrophages, and neutrophils) are the cellular hallmark
of in£ammation. One important pathway for the generation
of reactive species by phagocytes involves the enzyme myelo-
peroxidase (MPO), a secreted heme protein [13]. Together
with H2O2 MPO oxidizes chloride to hypochlorous acid
(HOCl), a potent microbicidal agent which can oxidize
many biological substances including LDL [14]. HOCl oxi-
dizes thiols, reacts with unsaturated fatty acids in LDL to
form chlorohydrins [15], and covalently modi¢es amino
groups of proteins, disrupting the tertiary structure and func-
tion of target proteins (reviewed in [16]). Catalytically active
MPO is present in human atherosclerotic lesions [17] suggest-
ing that MPO promotes LDL oxidation in vivo.
To date, the origin of LDL3 remains unclear, although its
role in atherogenesis is emerging. Three possible sources of
LDL3 are discussed: (i) oxidation of LDL entrapped in the
arterial wall [18], (ii) ingestion of oxidants or generation from
postprandial lipoprotein remnants [19], and (iii) oxidation in
plasma [20]. Our study reveals a potential role of HOCl in the
generation of LDL3 as a further mechanism. Localized in-
£ammation and MPO secretion may account for increases
in plasma LDL3 levels. At high concentrations HOCl has
been found to modify LDL predominantly to LDL23. By
contrast, low concentrations of HOCl favor formation of
LDL3. Our ¢ndings indicate that LDL3 may be formed pref-
erentially when readily oxidizable thioether groups, such as
methionine, are present. By contrast, extensive oxidation
yielding LDL3 is not suppressed by methionine suggesting
that LDL3 formation by HOCl involves quantitative LDL
oxidation via chloramines that subsequently decompose, re-
versibly oxidize or chlorinate other susceptible target mole-
cules.
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2. Materials and methods
2.1. Materials
All reagents were of AR grade and obtained from either Merck
(Darmstadt, Germany) or Sigma (St. Louis, MO, USA) if not other-
wise stated.
2.2. Plasma preparation
Blood was drawn by venipuncture from one healthy normolipidem-
ic volunteer after overnight fasting and plasma was immediately sep-
arated by low spin centrifugation at 1500Ug for 10 min at 4‡C.
Sucrose solution (60% w/v) was added (¢nal concentration 0.6%)
and aliquots were stored at 380‡C in the dark until LDL preparation
(up to 2 months) [21].
2.3. Preparation of LDL and lipoprotein-de¢cient plasma (LDP)
LDL (d = 1.019^1.063 g/ml) and LDP (bottom fraction; d = 1.41 g/
ml) were prepared from plasma by discontinuous density gradient
ultracentrifugation [21] and stored under nitrogen at 4‡C in the
dark for up to 1 week after preparation. LDL (but not LDP) was
gel ¢ltrated with an Econo-Pac 10 DG column (Bio-Rad, Richmond,
CA, USA) using phosphate-bu¡ered saline (PBS, 150 mM NaCl, 10
mM NaH2PO4WH2O, pH 7.4) containing 0.1% ethylenediaminetetra-
acetic acid (EDTA) (w/v) as an eluent. LDL cholesterol content was
determined by the CHOD-PAD method using a commercial kit
(Roche, Mannheim, Germany). Protein concentration was measured
using a Protein Microtiter Plate assay (Bio-Rad, Richmond, CA,
USA).
2.4. LDL oxidation
LDL (0.3 WM) was titrated with HOCl at various concentrations
(0.03 WM up to 30 mM) in PBS pH 7.4 EDTA and incubated for
either 1 or 60 min at 37‡C under aerobic conditions. Diluted HOCl
was prepared in double-distilled water always freshly prepared prior
to oxidation. Immediately after initiation of oxidation by HOCl, ali-
quots (0.3 ml) were taken and the kinetics of the formation of con-
jugated dienes monitored for up to 2 h at 234 nm in a Beckman DU
640 spectrophotometer [22]. At the end of the respective reaction
times, selected samples were incubated with L-methionine at a ¢ve-
fold molar ratio compared to HOCl. The reaction mixtures were gel
¢ltrated with an Econo-Pac 10 DG column thereby separating LDL
from any unreacted HOCl and/or methionine, and eluted with 20 mM
Tris^HCl pH 7.2. LDL was then subjected to HPLC analysis as de-
scribed below. 3 Wl of unmodi¢ed LDL, or of the reaction mixtures
obtained immediately after addition of HOCl, or of modi¢ed LDL
(after removal of HOCl by gel ¢ltration) was loaded on Beckman
Paragon Lipo-gels and the relative electrophoretic mobility (REM)
determined according to the manufacturer’s instructions.
2.5. Separation of LDL subspecies by HPLC
LDL in 20 mM Tris^HCl pH 7.2 was separated into subfractions
according to the method described by Hodis et al. [11] with minor
modi¢cations [23].
2.6. Reisolation of LDL oxidized in the presence of LDP
Samples consisting of 0.3 WM LDL in medium containing undia-
lyzed LDP (5^20%, v/v) were exposed to HOCl as described above.
Sample density was adjusted to 1.25 g/cm3 by adding 0.38 g solid
NaBr/ml, and overlayered with 4 ml of 1.25, 2 ml of 1.05, and 3 ml
of 1.0 g/cm3 NaBr^EDTA (0.1%, pH 7.4). Ultracentrifugation using a
Beckman SW41 rotor was carried out at 5‡C for 22 h at 40 000 rpm in
a Beckman L-70 ultracentrifuge. The reisolated LDL band was col-
lected and immediately subjected to HPLC analysis as described
above.
SDS^PAGE was performed [24] for the detection of possible cova-
lent aggregates due to modi¢cations of LDL by HOCl.
2.7. Statistics
Values are expressed as mean þ S.D. of at least three independent
experiments. Statistical analysis (ANOVA) was performed using Sig-
maStat 2.03 software.
3. Results
3.1. Formation of LDL subspecies by low concentrations of
HOCl
HPLC separation of unmodi¢ed LDL revealed the follow-
ing baseline pattern of LDL subfractions: 99.7 þ 0.05%
nLDL, 0.18 þ 0.04% LDL3, and 0.09 þ 0.02% LDL23. Sub-
jecting LDL to oxidation by HOCl over 60 min at 37‡C at
a molar HOCl/LDL ratio as low as 10:1 led to a 17-fold
increase in both LDL3 and LDL23. Raising the HOCl/LDL
molar ratio to 100:1 further increased the levels of LDL3 and
LDL23 by 22-fold and 19-fold, respectively (Fig. 1).
3.2. Impact of incubation time on the generation of LDL3 and
LDL23 by HOCl
After an incubation time of only 1 min at a low molar
HOCl to LDL ratio, LDL3 was the predominant species gen-
erated compared to LDL23 levels (Fig. 2A). Above a HOCl/
LDL ratio of 3000, LDL23 levels (V14%) exceeded those of
LDL3 (V8%). 60 min of incubation (Fig. 2B) did not mark-
edly alter LDL3 levels compared to 1 min of incubation, but
increased LDL23 signi¢cantly, i.e. V24% of LDL23 after 60
min compared to V14% after 1 min. Circular dichroism mea-
surement of all 60 min samples revealed no increase in absor-
bance; SDS^PAGE showed aggregation only at the highest
HOCl concentrations used (data not shown).
3.3. Methionine reduces the formation of LDL23
Post-addition of L-methionine suppressed LDL23 formation
by HOCl but did not alter LDL3 levels signi¢cantly regard-
less of incubation time (Fig. 3). Furthermore, L-methionine
led to a signi¢cant decrease in REM indicating LDL23 to
be a major contributing factor of the increase in the REM
of oxidized LDL (Fig. 4).
3.4. LDP does not prevent the formation of LDL3 and LDL23
by HOCl
Oxidation of LDL in the presence of up to 20% LDP de-
creased the generation of LDL subspecies compared with
HOCl alone. However, even 20% (v/v) LDP could not prevent
the HOCl-induced ¢ve-fold increase of both LDL3 and
LDL23 concentrations (Fig. 5). The inhibitory e¡ect was
not dose-related for LDL3 formation but was for LDL23.
Fig. 1. Formation of LDL3 and LDL23 by HOCl. B: Plasma base-
line levels of LDL3 and LDL23. 1, 10, 100: LDL was titrated with
increasing HOCl concentrations, and subspecies were separated by
HPLC after 60 min of incubation at 37‡C. Values represent
mean þ S.D. (n = 3). ANOVA analysis of LDL3 and LDL23 com-
pared to B: **P6 0.001.
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4. Discussion
Our observations indicate that (i) HOCl generates LDL3
and LDL23 ; (ii) HOCl increases the negative charge of LDL
in a concentration- rather than time-dependent manner; (iii)
post-addition of methionine leads to the preferential forma-
tion of LDL3 over LDL23 ; and (iv) LDL3 formation by
HOCl prevails in the presence of LDP.
Modi¢cation of LDL by HOCl lowers the number of sulf-
hydryl and amino groups and increases the negative charge
density of the LDL surface [25] which is in line with the
detected increase in REM in this study. One reason for the
more negatively charged surface of HOCl-altered LDL is the
possible formation of monochloramines. While amino groups
have a positive charge at physiological pH values, monochlor-
amines are uncharged [26]. Moreover, the side chains of cys-
teine, methionine, tryptophan and tyrosine were shown to be
of higher reactivity towards HOCl compared with lysine res-
idues of lipoproteins [27]. LDL3 formation at low concentra-
tions of HOCl in the micromolar range can therefore be at-
tributed to sulfhydryls, tryptophans and tyrosines as targets of
an electrophilic substitution by HOCl in addition to oxida-
tion/chlorination of lysyl residues.
LDL-bound chloramines might be formed at higher HOCl/
LDL ratios. Indeed, distinctive peaks at 253 and 248 nm ^
indicative of chloramines (published absorption maxima range
from 240 to 270 nm [28,29]) ^ were observed in HOCl-treated
LDL even in the presence of L-methionine added to prevent
further and extensive oxidation (data not shown). Subsequent
addition of methionine led to preferential formation of LDL3
over LDL23. In principle, there are three possible pathways of
methionine consumption by either HOCl or chloramines.
First, free L-methionine might act as a HOCl scavenger by
virtue of the thioether group scavenging up to three molecules
of HOCl which leads to a sulfone residue via an intermediate
sul¢nylchloride and sulfoxide [30]. In our experiments, L-me-
thionine was added 1 or 60 min after the start of the reaction
between HOCl and LDL. Already after 1 min of incubation,
at least in the case of low HOCl/LDL molar ratios, all mol-
ecules of HOCl will have reacted with the estimated 987 ami-
no acid residues (i.e. sum of His, Cys, Met, Trp, Lys, Tyr and
Phe) principally susceptible to chlorination/oxidation by
HOCl [27]. It has also been shown that several residues are
capable of consuming more than one molecule of HOCl [16].
It is therefore conceivable that under these conditions HOCl
reacts quantitatively with LDL, and that addition of methio-
nine after 1 or 60 min can lead to methionine^chloramine
interactions rather than scavenging HOCl.
The second pathway of methionine reacting with HOCl
and/or chloramines is based on the reversibility of chloramine
formation by HOCl. A protein-bound amino group reacts
with HOCl forming a chloramine [31]. The labile LDL-bound
chloramine may liberate HOCl, and in the presence of targets
susceptible to chlorination/oxidation, including free methio-
nine, HOCl may either form another chloramine on the target
molecule or otherwise modify LDL as described above.
Third, chloramines may decompose by a reaction that in-
volves the generation of radical species. Homolytic cleavage of
the N^Cl bond could form a protein-bound nitrogen-centered
radical and a chlorine radical. These nitrogen-centered radi-
cals have been shown to account for fragmentation, protein
modi¢cation [32], and lipid peroxidation of LDL [33]. There
are few indications for lipid peroxidation due to the observed
lack of increase of absorption at 234 nm. This is in line with a
recent study where neither epoxides nor peroxides were detect-
able, but solely chlorohydrins [15]. Decomposition of lysyl
chloramines was shown to occur at millimolar concentrations
Fig. 2. Time-dependent formation of LDL3 and LDL23 by HOCl.
LDL was titrated with increasing HOCl concentrations, and subspe-
cies were separated by HPLC after 1 min (A) or 60 min (B) of incu-
bation at 37‡C. Values represent mean þ S.D. (n = 3).
Fig. 3. In£uence of L-methionine on HOCl-dependent generation of
LDL3 and LDL23 by HOCl. LDL was titrated with increasing
HOCl concentrations, L-methionine was added after 1 min of incu-
bation at 37‡C, and LDL subspecies separated by HPLC. Values
represent mean þ S.D. (n = 3).
 
Fig. 4. Representative agarose gel showing the change in REM of LDL titrated with increasing HOCl concentrations, and the in£uence of
L-methionine addition after 1 min of incubation at 37‡C.
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of HOCl, hence it might only proceed at the highest molar
HOCl/LDL ratio in our experiments.
By hydrolysis of an intermediate imine (Eq. 1), K-chlor-
amines can break down to aldehydes (Eq. 2), concomitantly
releasing ammonia [34] :
R-CH2-NHCl! R-CHNNHHCl 1
R-CHNNHH2OHR-CHNONH3 2
O-Amino groups are likely to undergo similar reactions,
therefore aldehydes formed on lysyl residues of LDL might
interact, in a reversible reaction, with another O-amino group
leading to a Schi¡ base, a reaction which invokes inter- as well
as intraparticle crosslinks causing aggregation as a conse-
quence. SDS^PAGE revealed aggregation at high concentra-
tions of HOCl, but hardly any increase in molecular weight at
low molar HOCl/LDL ratios.
Most pathways which promote LDL oxidation in vitro are
strongly inhibited by plasma. In contrast, HOCl converts
LDL to LDL3 and LDL23 in the presence of LDP. Chlor-
amines formed by HOCl on LDP proteins may lead to oxi-
dation/chlorination of LDL. This important observation sug-
gests that the conversion of LDL to more electronegative
species by HOCl secreted by activated, circulating phagocytes
can indeed occur in the circulation and may be physiologically
relevant.
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Fig. 5. LDL oxidation by HOCl in the presence of LDP. B: Plasma
baseline levels of LDL3 and LDL23 ; 0: oxidation of isolated LDL
by HOCl (7000:1 mol/mol) in the absence of LDP. 5^20: LDP (5^
20% v/v) together with 0.3 WM LDL was oxidized by HOCl (7000:1
mol/mol) for 1 min at 37‡C. Samples were ultracentrifuged to reiso-
late LDL, and LDL subspecies separated by HPLC. Values repre-
sent mean þ S.D. (n = 3). ANOVA showed highly signi¢cant di¡eren-
ces for LDL23 (**P6 0.001), and signi¢cant di¡erences for LDL3
(*P6 0.05) compared to B.
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